Real-time enrollment status for this invasive aspergillosis clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT05101187 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Invasive Aspergillosis |
| Phase | Clinical Trial |
| Target Enrollment | 225 participants |
| Active Locations | 24 sites in the US |
| Sponsor | F2G Biotech GmbH |
| Last Updated on CT.gov | January 6, 2026 (Jan 6, 2026) |
As of March 2, 2026: Clinical trial NCT05101187 is currently active_not_recruiting participants. This clinical trial study for invasive aspergillosis is not currently accepting new participants at 24 locations across the United States. The study is sponsored by F2G Biotech GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05101187 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05101187 was last updated Jan 6, 2026 (January 6, 2026). HelloStudys verifies this status automatically.